Lakefront Biotherapeutics reported EUR2.01B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 60.01B 2.38B Sep/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Biogen USD 33.38B 1.48B Sep/2026
Genmab DKK 17.1B 88.06B Jun/2026
Gilead Sciences USD 184.82B 27.96B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
GRIFOLS EUR 4.76B 1.02B Nov/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Incyte USD 24.6B 1.95B Sep/2026
Merck EUR 64.74B 46.89B Nov/2026
Neurocrine Biosciences USD 16.38B 1.96B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
UCB EUR 46.41B 13.94B Dec/2025
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026